Does BOTULINUM TOXIN TYPE A Cause Drug specific antibody? 87 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 87 reports of Drug specific antibody have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 2.3% of all adverse event reports for BOTULINUM TOXIN TYPE A.
87
Reports of Drug specific antibody with BOTULINUM TOXIN TYPE A
2.3%
of all BOTULINUM TOXIN TYPE A reports
0
Deaths
1
Hospitalizations
How Dangerous Is Drug specific antibody From BOTULINUM TOXIN TYPE A?
Of the 87 reports, 1 (1.1%) required hospitalization.
Is Drug specific antibody Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 87 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Drug specific antibody?
INFLIXIMAB (684)
ADALIMUMAB (576)
METHOTREXATE (258)
PREDNISONE (219)
ETANERCEPT (133)
ABATACEPT (127)
SULFASALAZINE (124)
TOCILIZUMAB (123)
HYDROXYCHLOROQUINE (122)
ANAKINRA (114)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Drug specific antibody Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE